ZA200606174B - Multiparticulate formulations for oral delivery - Google Patents

Multiparticulate formulations for oral delivery

Info

Publication number
ZA200606174B
ZA200606174B ZA200606174A ZA200606174A ZA200606174B ZA 200606174 B ZA200606174 B ZA 200606174B ZA 200606174 A ZA200606174 A ZA 200606174A ZA 200606174 A ZA200606174 A ZA 200606174A ZA 200606174 B ZA200606174 B ZA 200606174B
Authority
ZA
South Africa
Prior art keywords
oral delivery
multiparticulate formulations
multiparticulate
formulations
oral
Prior art date
Application number
ZA200606174A
Other languages
English (en)
Inventor
Morton David
Simpson David
Staniforth John
Original Assignee
Pharma Kodex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Kodex Ltd filed Critical Pharma Kodex Ltd
Publication of ZA200606174B publication Critical patent/ZA200606174B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200606174A 2003-12-31 2006-07-26 Multiparticulate formulations for oral delivery ZA200606174B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0330255.1A GB0330255D0 (en) 2003-12-31 2003-12-31 Multiparticulate formulations for oral delivery

Publications (1)

Publication Number Publication Date
ZA200606174B true ZA200606174B (en) 2008-10-29

Family

ID=31503344

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200606174A ZA200606174B (en) 2003-12-31 2006-07-26 Multiparticulate formulations for oral delivery

Country Status (12)

Country Link
US (1) US20070154549A1 (fr)
EP (1) EP1706101A2 (fr)
JP (1) JP2007517011A (fr)
CN (1) CN1921836A (fr)
AU (1) AU2004308741A1 (fr)
BR (1) BRPI0418275A (fr)
CA (1) CA2551662A1 (fr)
GB (1) GB0330255D0 (fr)
NZ (1) NZ548168A (fr)
SG (1) SG149054A1 (fr)
WO (1) WO2005063203A2 (fr)
ZA (1) ZA200606174B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
US20160045457A1 (en) 2005-09-09 2016-02-18 Ousama Rachid Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine
US9877921B2 (en) 2005-09-09 2018-01-30 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
US20070077300A1 (en) 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
WO2007106957A1 (fr) * 2006-03-21 2007-09-27 Laboratoires Smb S.A. Formes galéniques flottantes multiples à libération contrôlée
GB2443793B (en) 2006-04-05 2010-12-01 Reckitt Benckiser Healthcare Product, method of manufacture and use
WO2008024719A2 (fr) * 2006-08-21 2008-02-28 Tiax Llc Compositions permettant de réduire un goût et procédés associés
GB0616794D0 (en) 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
CN101084881B (zh) * 2007-06-23 2012-08-29 淮北辉克药业有限公司 靶向速释泡腾制剂及其制备方法
EP2198859A1 (fr) * 2008-12-17 2010-06-23 Losan Pharma GmbH Composition pharmaceutique à revêtement par fusion avec libération
US20120322884A1 (en) 2010-03-01 2012-12-20 University Of Manitoba Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
MX2014004480A (es) * 2011-10-12 2015-04-09 Delavau Llc Complementos alimenticios con disolución bucal rapida.
EP2753321B1 (fr) 2011-10-21 2021-12-15 Nova Southeastern University Nanoparticules d'épinéphrine, leurs procédés de fabrication et leurs procédés d'utilisation pour le traitement d'états sensibles à l'épinéphrine
CA3169368A1 (fr) 2012-06-15 2014-01-09 Nova Southeastern University Nanoparticules d'epinephrine, procede pour les fabriquer et procedes pour les utiliser pour le traitement d'affections repondant a l'epinephrine
EP3888642A1 (fr) 2013-03-22 2021-10-06 Nova Southeastern University Particules fines d'épinéphrine et leurs procédés d'utilisation pour le traitement d'états pathologiques réagissant à l'épinéphrine
DK3003285T3 (en) 2013-06-03 2022-04-04 Mcneil Ab Fast farmaceutisk dosisform til frigivelse af mindst to aktive farmaceutiske ingredienser i mundhulen
KR102017550B1 (ko) * 2013-11-13 2019-09-03 내셔널 디펜스 에듀케이션 앤드 리서치 파운데이션 간에 대한 부작용이 없는 신규의 아세트아미노펜 화합물 조성물
ES2749866T3 (es) * 2014-05-01 2020-03-24 Hermes Arzneimittel Gmbh Formulaciones orales sólidas que comprenden dispersiones fundidas sólidas de ácidos orgánicos en xilitol
EP3346986A1 (fr) * 2015-09-11 2018-07-18 Andrew Guise Composition particulaire orale
JP6858729B2 (ja) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2636152C2 (de) * 1976-08-11 1980-11-06 Arcana Chem.-Pharm. Fabrik Gmbh, Spittal, Drau (Oesterreich) Verfahren zur Herstellung von Dragees
JPH07100665B2 (ja) * 1987-12-23 1995-11-01 信越化学工業株式会社 被覆薬剤の製造方法
JP3130058B2 (ja) * 1991-02-15 2001-01-31 第一製薬株式会社 マスクされた粒状物
IT1312058B1 (it) * 1999-04-09 2002-04-04 Pharmaplus S R L Metodo per la microincapsulazione di medicamenti.
US6941948B2 (en) * 2002-03-07 2005-09-13 Vectura Drug Delivery Medicament storage and delivery devices

Also Published As

Publication number Publication date
GB0330255D0 (en) 2004-02-04
BRPI0418275A (pt) 2007-05-02
SG149054A1 (en) 2009-01-29
CN1921836A (zh) 2007-02-28
CA2551662A1 (fr) 2005-07-14
US20070154549A1 (en) 2007-07-05
WO2005063203A2 (fr) 2005-07-14
WO2005063203A3 (fr) 2005-12-01
AU2004308741A1 (en) 2005-07-14
JP2007517011A (ja) 2007-06-28
NZ548168A (en) 2009-09-25
EP1706101A2 (fr) 2006-10-04

Similar Documents

Publication Publication Date Title
ZA200606174B (en) Multiparticulate formulations for oral delivery
AU2003209475A1 (en) Fast melt multiparticulate formulations for oral delivery
IL174432A0 (en) Pantoprazole multiparticulate formulations
IL162642A0 (en) Formulations
GB0210397D0 (en) Pharmaceutical formulations
IL172824A0 (en) Pharmaceutical formulations
HK1107768A1 (en) Solid drug for oral use
GB0302671D0 (en) Pharmaceutical formulations
GB0323701D0 (en) Formulations
GB2392093B (en) Pharmaceutical formulations
GB0302672D0 (en) Pharmaceutical formulations
HK1092715A1 (en) Melt-formulated, multi-particulate oral dosage form
GB0325383D0 (en) Oral formulations
AU2003229199A8 (en) Liposome vaccine formulations for fin-fish
GB0316341D0 (en) Pharmaceutical formulations
IL174308A0 (en) Therapeutic formulations
GB0307765D0 (en) Tissue-adhesive formulations
EP1614417A4 (fr) Preparation solide pour l'usage par voie orale
IL173743A0 (en) Oral itrazole compositions
ZA200803553B (en) Oral formulations comprising 3'-azidonucleosides
IL174699A0 (en) Vaccine for periodontal disease
ZA200204905B (en) Improved pharmaceutical dental formulations.
GB0316335D0 (en) Pharmaceutical formulations
AU2003303145A8 (en) Formulations for pulmonary delivery
GB0324912D0 (en) Pharmaceutical formulations